Source: Newsday

InvaGen Pharmaceuticals: After pushback on number of workers, drugmaker drops request for tax breaks

Even without breaks, InvaGen has renewed its lease agreement in Hauppauge and plans to continue operating as usual, a spokeswoman says.Â

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Nikhil Lalwani's photo - CEO of InvaGen Pharmaceuticals

CEO

Nikhil Lalwani

CEO Approval Rating

70/100

Read more